252 related articles for article (PubMed ID: 17482783)
1. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
Wang L; Jiang X; Xu W; Li C
Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of beta-cyclodextrin and its water-soluble derivatives on in vitro drug transport across rat intestinal epithelium.
Zheng Y; Zuo Z; Chow AH
Int J Pharm; 2006 Feb; 309(1-2):123-8. PubMed ID: 16359834
[TBL] [Abstract][Full Text] [Related]
3. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
Sridevi S; Chauhan AS; Chalasani KB; Jain AK; Diwan PV
Pharmazie; 2003 Nov; 58(11):807-10. PubMed ID: 14664337
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complex of trimethoprim with beta-cyclodextrin.
Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
7. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
Ozdemir N; Ordu S
Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
[TBL] [Abstract][Full Text] [Related]
8. Availability of phenindione-beta-cyclodextrin inclusion complex.
Tous SS; el-Sayed AM; el-Harras SA; Jun HW
Pharmazie; 1992 May; 47(5):365-8. PubMed ID: 1409827
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
11. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
12. Preparation and study on the inclusion complexes of two tanshinone compounds with beta-cyclodextrin.
Yuexian F; Junfen L; Chuan D
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):135-40. PubMed ID: 15556431
[TBL] [Abstract][Full Text] [Related]
13. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
Mura P; Bettinetti GP; Cirri M; Maestrelli F; Sorrenti M; Catenacci L
Eur J Pharm Biopharm; 2005 Jan; 59(1):99-106. PubMed ID: 15567306
[TBL] [Abstract][Full Text] [Related]
14. Study of insolubility problems of dexamethasone and digoxin: cyclodextrin complexation.
Dilova V; Zlatarova V; Spirova N; Filcheva K; Pavlova A; Grigorova P
Boll Chim Farm; 2004; 143(1):20-3. PubMed ID: 15085571
[TBL] [Abstract][Full Text] [Related]
15. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
[TBL] [Abstract][Full Text] [Related]
16. Effect of pH and complexation on transdermal permeation of gliquidone.
Sridevi S; Diwan PV
Pharmazie; 2002 Sep; 57(9):632-4. PubMed ID: 12369452
[TBL] [Abstract][Full Text] [Related]
17. [Study on preparation of the inclusion compound of curcumin with beta-cyclodextrin].
Han G; Xu J; Li W; Ning C
Zhong Yao Cai; 2004 Dec; 27(12):946-8. PubMed ID: 15807250
[TBL] [Abstract][Full Text] [Related]
18. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
19. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
Kopecký F; Kopecká B
Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
[TBL] [Abstract][Full Text] [Related]
20. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]